Cutting Edge Research Group /ID# 236664 — Oklahoma City, Oklahoma

Cutting Edge Research Group /ID# 236664 is a clinical research site located in Oklahoma City, Oklahoma, United States 73116-1423.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cutting Edge Research Group /ID# 236664 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cutting Edge Research Group /ID# 236664?

Cutting Edge Research Group /ID# 236664 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cutting Edge Research Group /ID# 236664 conducted?

Cutting Edge Research Group /ID# 236664 has 1 clinical trials on record. Their work covers Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD).

Is Cutting Edge Research Group /ID# 236664 accredited by Crixeo Health?

Cutting Edge Research Group /ID# 236664 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cutting Edge Research Group /ID# 236664?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.